TM2D2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.446600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.461780E-01
Normal-vs-Stage2
8.135200E-01
Normal-vs-Stage3
8.681000E-01
Normal-vs-Stage4
5.984400E-01
Stage1-vs-Stage2
1.026090E-02
Stage1-vs-Stage3
2.530600E-01
Stage1-vs-Stage4
5.680000E-02
Stage2-vs-Stage3
9.546800E-01
Stage2-vs-Stage4
8.772600E-01
Stage3-vs-Stage4
8.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.711000E-01
Normal-vs-AfricanAmerican
8.670200E-01
Normal-vs-Asian
7.642200E-01
Caucasian-vs-AfricanAmerican
9.758200E-01
Caucasian-vs-Asian
9.138600E-01
AfricanAmerican-vs-Asian
8.992000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.541800E-01
Normal-vs-Female
8.296600E-01
Male-vs-Female
9.533800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.498200E-01
Normal-vs-Age(41-60Yrs)
4.137000E-01
Normal-vs-Age(61-80Yrs)
9.574800E-01
Normal-vs-Age(81-100Yrs)
6.110000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.237000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.428000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.151400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.960300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.156000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.117000E-01
Normal-vs-Daily Drinker
6.399000E-01
Normal-vs-Weekly Drinker
6.239600E-01
Normal-vs-Occasional Drinker
6.644400E-01
Normal-vs-Social Drinker
9.581800E-01
Non Drinker-vs-Daily Drinker
3.698000E-01
Non Drinker-vs-Weekly Drinker
5.411200E-01
Non Drinker-vs-Occasional Drinker
7.677200E-01
Non Drinker-vs-Social Drinker
8.379800E-01
Daily Drinker-vs-Weekly Drinker
1.444440E-01
Daily Drinker-vs-Occasional Drinker
9.202100E-02
Daily Drinker-vs-Social Drinker
3.919600E-01
Weekly Drinker-vs-Occasional Drinker
6.288400E-01
Weekly Drinker-vs-Social Drinker
3.757800E-01
Occasional Drinker-vs-Social Drinker
5.381000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.997000E-01
Normal-vs-Grade 2
1.812610E-01
Normal-vs-Grade 3
2.406200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.970000E-02
Grade 1-vs-Grade 3
1.187770E-02
Grade 1-vs-Grade 4
4.997000E-01
Grade 2-vs-Grade 3
1.686040E-01
Grade 2-vs-Grade 4
1.812610E-01
Grade 3-vs-Grade 4
2.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.226600E-01
Normal-vs-NonDiabetic
7.676200E-01
Diabetic-vs-NonDiabetic
2.209600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.838400E-01
Normal-vs-NoPancreatitis
8.211000E-01
Pancreatitis-vs-NoPancreatitis
3.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.480800E-01
Normal-vs-N1
7.719200E-01
N0-vs-N1
1.658190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.536800E-01
Normal-vs-TP53-NonMutant
3.479400E-01
TP53-Mutant-vs-TP53-NonMutant
4.439200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
